Cargando…

SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa

By November 2021, after the third wave of severe acute respiratory syndrome coronavirus 2 infections in South Africa, seroprevalence was 60% in a rural community and 70% in an urban community. High seroprevalence before the Omicron variant emerged may have contributed to reduced illness severity obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleynhans, Jackie, Tempia, Stefano, Wolter, Nicole, von Gottberg, Anne, Bhiman, Jinal N., Buys, Amelia, Moyes, Jocelyn, McMorrow, Meredith L., Kahn, Kathleen, Gómez-Olivé, F. Xavier, Tollman, Stephen, Martinson, Neil A., Wafawanaka, Floidy, Lebina, Limakatso, du Toit, Jacques D., Jassat, Waasila, Neti, Mzimasi, Brauer, Marieke, Cohen, Cheryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045427/
https://www.ncbi.nlm.nih.gov/pubmed/35320701
http://dx.doi.org/10.3201/eid2805.220278
_version_ 1784695314324652032
author Kleynhans, Jackie
Tempia, Stefano
Wolter, Nicole
von Gottberg, Anne
Bhiman, Jinal N.
Buys, Amelia
Moyes, Jocelyn
McMorrow, Meredith L.
Kahn, Kathleen
Gómez-Olivé, F. Xavier
Tollman, Stephen
Martinson, Neil A.
Wafawanaka, Floidy
Lebina, Limakatso
du Toit, Jacques D.
Jassat, Waasila
Neti, Mzimasi
Brauer, Marieke
Cohen, Cheryl
author_facet Kleynhans, Jackie
Tempia, Stefano
Wolter, Nicole
von Gottberg, Anne
Bhiman, Jinal N.
Buys, Amelia
Moyes, Jocelyn
McMorrow, Meredith L.
Kahn, Kathleen
Gómez-Olivé, F. Xavier
Tollman, Stephen
Martinson, Neil A.
Wafawanaka, Floidy
Lebina, Limakatso
du Toit, Jacques D.
Jassat, Waasila
Neti, Mzimasi
Brauer, Marieke
Cohen, Cheryl
author_sort Kleynhans, Jackie
collection PubMed
description By November 2021, after the third wave of severe acute respiratory syndrome coronavirus 2 infections in South Africa, seroprevalence was 60% in a rural community and 70% in an urban community. High seroprevalence before the Omicron variant emerged may have contributed to reduced illness severity observed in the fourth wave.
format Online
Article
Text
id pubmed-9045427
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-90454272022-05-07 SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa Kleynhans, Jackie Tempia, Stefano Wolter, Nicole von Gottberg, Anne Bhiman, Jinal N. Buys, Amelia Moyes, Jocelyn McMorrow, Meredith L. Kahn, Kathleen Gómez-Olivé, F. Xavier Tollman, Stephen Martinson, Neil A. Wafawanaka, Floidy Lebina, Limakatso du Toit, Jacques D. Jassat, Waasila Neti, Mzimasi Brauer, Marieke Cohen, Cheryl Emerg Infect Dis Research Letter By November 2021, after the third wave of severe acute respiratory syndrome coronavirus 2 infections in South Africa, seroprevalence was 60% in a rural community and 70% in an urban community. High seroprevalence before the Omicron variant emerged may have contributed to reduced illness severity observed in the fourth wave. Centers for Disease Control and Prevention 2022-05 /pmc/articles/PMC9045427/ /pubmed/35320701 http://dx.doi.org/10.3201/eid2805.220278 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Kleynhans, Jackie
Tempia, Stefano
Wolter, Nicole
von Gottberg, Anne
Bhiman, Jinal N.
Buys, Amelia
Moyes, Jocelyn
McMorrow, Meredith L.
Kahn, Kathleen
Gómez-Olivé, F. Xavier
Tollman, Stephen
Martinson, Neil A.
Wafawanaka, Floidy
Lebina, Limakatso
du Toit, Jacques D.
Jassat, Waasila
Neti, Mzimasi
Brauer, Marieke
Cohen, Cheryl
SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa
title SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa
title_full SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa
title_fullStr SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa
title_full_unstemmed SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa
title_short SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa
title_sort sars-cov-2 seroprevalence after third wave of infections, south africa
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045427/
https://www.ncbi.nlm.nih.gov/pubmed/35320701
http://dx.doi.org/10.3201/eid2805.220278
work_keys_str_mv AT kleynhansjackie sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT tempiastefano sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT wolternicole sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT vongottberganne sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT bhimanjinaln sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT buysamelia sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT moyesjocelyn sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT mcmorrowmeredithl sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT kahnkathleen sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT gomezolivefxavier sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT tollmanstephen sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT martinsonneila sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT wafawanakafloidy sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT lebinalimakatso sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT dutoitjacquesd sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT jassatwaasila sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT netimzimasi sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT brauermarieke sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT cohencheryl sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica
AT sarscov2seroprevalenceafterthirdwaveofinfectionssouthafrica